Figure 3.
Network of interventions introduced into the network meta-analysis for ALT outcome.
Legend: Feno: fenofibrate, Ezet: ezetimbe, Exen: exenatide, Coles: Colesevelam, Bicy: bicycline, Beta: betaine, Atrp: atrovastatin, Antiox: anti-oxidants, Vit-E: vitamin- E, Vida:vidagliptin, UDCA: Ursodeoxycholic acid, Tryp: tryptophan, Toco: Tocotrienol, Telm: telmisartan, Synb:symbiotic, SOC: Standard of Care, Sita: sitagliptin, Silly:silymarin, Rosi: rosiglitazone, Resv: Resveratrol, Probu: probucol, Prob: probiotic, Plac:placebo, Piog: pioglitazone, Pant: Pentoxifylline, Orli: Orlistat, Omeg3: Omega-3, Obet: obeticholic acid, Met: metformin, Mela: Melatonin, Lpra: Ipragliflozin, Losa; losartan, Lira: liraglutide, L-Car: L-carnitine, Insu: insulin, Glicl: gliclazide